Trials / Completed
CompletedNCT02897154
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
Clinical Evaluation of i-STAT Analyzer for Glucose, Hematocrit and Sodium
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 297 (actual)
- Sponsor
- Abbott Point of Care · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to compare the performance of two i-STAT Analyzers in a Point-of-Care (POC) setting. The evaluation will be performed using a cartridge to test glucose, hematocrit and sodium on capillary specimens.
Detailed description
The clinical performance for glucose, hematocrit and sodium assays for capillary samples was evaluated for the investigational i-STAT 500 (Alinity) analyzer based on results of method comparison testing against the i-STAT 1W analyzer.
Conditions
- Analytical Performance of Sodium, Glucose and Hematocrit Assays by the i-STAT 500 (Alinity) Analyzer
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | In-vitro |
Timeline
- Start date
- 2016-05-10
- Primary completion
- 2017-03-15
- Completion
- 2017-03-15
- First posted
- 2016-09-13
- Last updated
- 2018-03-20
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02897154. Inclusion in this directory is not an endorsement.